 |
Technical Support
(877) SEPAX-US, press 3  TechSupport@sepax-tech.com |
  |
| By Separation Mode | By Brand | By Sample Based Application | |
|
Size Exclusion Ion Exchange Hydrophobic Interaction Ion Exclusion Sub-2 UHPLC Purification Reversed Phase Mixed-mode Phase HILIC View All |
SEC-MALS Unix / Unix-C Zenix / Zenix-C SRT / SRT-C SRT-10 / SRT-10C Proteomix HIC / IEX Antibodix Carbomix Proteomix RP View All |
ADC Antibody Biosimilar Carbohydrate Cell Lysate DNA/RNA Fusion Protein Glycan Glycoprotein Heparin |
Insulin Membrane Protein Organic Acid PEG/PEGylated Protein Peptide Polymer Protein Vaccine/VLP Others |
How May We Help You?
How May We Help You?
How May We Help You?
Your question has been submitted.
We will respond back to you shortly.
We will respond back to you shortly.
How May We Help You?
Please fill out all required fields.
Samples
Sample: PeptidePeptide Recommended products
Size Exclusion:
Zenix
Zenix-C
SRT
SRT-C
Preparative SEC
Ion Exchange: Proteomix Antibodix Reversed phase: Proteomix RP Bio-C4
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Application Note
Featured Application Notes
All Application Notes
| App ID | Title |
| EE1005 | SEC Analysis of Insulin and HMW Aggregates | Size Exclusion@Size Exclusion@Size ExclusionZenix-CMethod Optimization@Pore Size Selection@Resolution@Lot to Lot@Sample Stability Test@Column Stability@AggregatesHPLC1
| EE1002 | Exenatide Analysis on Zenix SEC-80 | Size ExclusionZenixExenatide AnalysisHPLC1
| BE1004 | BE1004- Human serum albumin tryptic digest separation on reversed phase Bio-C18 | Reversed PhaseBio-C18Resolution@Method Optimization@Pore Size SelectionHPLC1
| EE1006 | Glucagon SEC Separation in 45% Acetonitrile with 0.1% TFA | Size ExclusionZenix-CVolatile Buffer@Method Optimization@ResolutionHPLC@LCMS1
| EE1004 | Insulin SEC Analysis | Size ExclusionZenix-CMethod Optimization@Pore Size Selection@Resolution@Lot to Lot@Sample Stability Test@Column Stability@AggregatesHPLC1
| GA1001 | Amino Acids on GP-C18 | Reversed PhaseGP-C18Resolution@Volatile BufferHPLC@LCMS1
| EE1003 | Transfer Factor Oral Solution SEC Separation | Size ExclusionZenix@Zenix-CParticle Size Impact@Pore Size Selection@Packing ChemistryHPLC1
| PE1003 | Peptide Separation on Proteomix SCX | Ion ExchangeProteomixFast Assay@Method Optimization@Particle Size ImpactHPLC@UHPLC@NanoLC1
| PE1002 | Analysis of Peptide Digest on Sub 2 µm Proteomix SCX | Ion ExchangeProteomixLoadingHPLC@UHPLC@NanoLC1
| ZE1009 | Analysis of Exenatide and Pegylated Exenatide on Zenix and Zenix-C SEC | Size ExclusionZenix@Zenix-CPacking Chemistry@Aggregates@Volatile Buffer@ResolutionHPLC@LCMS1
| PP1011 | Exenatide Acetate Analysis on Proteomix SCX | Ion ExchangeProteomixResolution@Volatile BufferHPLC@LCMS1
| ZZ1009 | Zenix and Zenix-C SEC-80 for Peptide Analysis | Size ExclusionZenixVolatile Buffer@Packing Chemistry@Volatile BufferHPLC@LCMS@NanoLC1
| BE1002 | Analysis on Microcystin on Bio-C18 | Reversed PhaseBio-C18Volatile BufferHPLC@LCMS1
| BE1001 | Analysis of a Peptide on Bio-C18 | Reversed Phase@Bio-C18Volatile BufferHPLC@LCMS1
| ZZ1007 | E.Coli Tryptic Digest on Zenix SEC-80 | Size ExclusionZenixResolutionHPLC1
| ZZ10061 | Peptide Separations Using Zenix SEC-80 | Size ExclusionZenixMethod Optimization@ResolutionHPLC1
| ZE1008 | Separation of 13.7 KD to 120 Da Peptide on Zenix-80 | Size ExclusionZenixResolutionHPLC2
| ZE1007 | Analysis of E.coli Tryptic Digest on Zenix SEC-80 | Size ExclusionZenixResolutionHPLC2
| ZE1006 | Four Peptide Mixture from 1kD to 6kD on Zenix SEC-80 | Size ExclusionZenixResolution@Volatile BufferHPLC@LCMS2
| ZP1010 | Separation of Asparaginase on Zenix SEC-150 | Size ExclusionZenixResolution@AggregatesHPLC2
| ZE1005 | Analysis of 5kD and 8kD Peptides by Zenix SEC-150 | Size ExclusionZenixResolutionHPLC2
| ZE1004 | Competition Comparison for Peptide Separation on SEC | Size ExclusionZenixCompetition ComparisonHPLC2
| ZE1002 | Analysis of Peptide Mixture on Zenix SEC -100 | Size ExclusionZenixResolution@Volatile BufferHPLC@LCMS2
| SP1007 | Analysis of Insulin on SRT SEC-150 | Size ExclusionSRTAggregatesHPLC2
| SE1001 | Separation of Peptide and Protein Mixture on SRT | Size ExclusionSRTPore Size SelectionHPLC2
| PE1001 | Separation of Peptide on Proteomix SCX with Volatile Buffer | Ion ExchangeProteomixVolatile BufferHPLC@LCMS2
| AE1001 | Gradient Impact on Peptide Analysis on Antibodix WCX | Ion ExchangeAntibodixMethod OptimizationHPLC2
| ZE1012 | Separation of Peptides and Small Proteins using Zenix SEC-100 | Size ExclusionZenixColumn Stability@Resolution@AggregatesHPLC2